Cargando…
Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options
Neglected diseases, primarily found in tropical regions of the world, present a significant challenge for impoverished populations. Currently, there are 20 diseases considered neglected, which greatly impact the health of affected populations and result in difficult-to-control social and economic co...
Autores principales: | Alves, Erick Tavares Marcelino, Pernichelle, Filipe Gomes, Nascimento, Lucas Adriano, Ferreira, Glaucio Monteiro, Ferreira, Elizabeth Igne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385647/ https://www.ncbi.nlm.nih.gov/pubmed/37513939 http://dx.doi.org/10.3390/ph16071028 |
Ejemplares similares
-
Prodrugs for the Treatment of Neglected Diseases
por: Chung, Man Chin, et al.
Publicado: (2008) -
Malaria and tuberculosis as diseases of neglected populations: state
of the art in chemotherapy and advances in the search for new
drugs
por: de Araújo, Renan Vinicius, et al.
Publicado: (2020) -
Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
por: Stahel, Philip F., et al.
Publicado: (2020) -
Neurofibromatosis 2: hearing restoration options
por: Monteiro, Tatiana Alves, et al.
Publicado: (2015) -
Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)